Insider · CIK 0001873794
Jean Felix Tematio
Files at UGI (UGI CORP /PA/). First filing Feb 13, 2026, latest Feb 13, 2026.
In brief
Jean Felix Tematio files SEC Form 4 as officer at UGI (UGI CORP /PA/). Since Feb 13, 2026, Jean Felix Tematio has reported 0 open-market buys worth $0 and 1 open-market sell worth $489k, the latest filed on Feb 13, 2026.
A track record needs three past buys with six months of prices behind them; Jean Felix Tematio has 0, so none is measured yet.
The newest scored trade: sold $489k of UGI on Feb 11, 2026, filed Feb 13, 2026, scored 38 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $489k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
UGI: UGI CORP /PA/
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | UGIsell UGI CORP /PA/ | $489k 12,840 shares | -65% | +30% from low-6% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 11, 2026 | UGI UGI CORPORATION | 12,840 0.01% of outstanding | $489k | Feb 11, 2026 | none |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | UGI UGI CORP /PA/ | MOption exercise UGI Common Stock | +12,840 | $24.60 | $316k | 19,792 | Feb 13, 2026 |
| Feb 11, 2026 | UGI UGI CORP /PA/ | SOpen-market sale UGI Common Stock | -12,840 | $38.07 | $489k | 6,952 | Feb 13, 2026 |
| Feb 11, 2026 | UGI UGI CORP /PA/ | MOption exercise Options (Right to Buy)derivative | -12,840 | $0.00 | $0 | 6,420 | Feb 13, 2026 |
| Jan 11, 2026 | UGI UGI CORP /PA/ | MOption exercise UGI Common Stock | +2,930 | $0.00 | $0 | 7,912 | Jan 13, 2026 |
| Jan 11, 2026 | UGI UGI CORP /PA/ | FTax withholding UGI Common Stock | -960 | $37.07 | $36k | 6,952 | Jan 13, 2026 |
| Jan 11, 2026 | UGI UGI CORP /PA/ | MOption exercise Stock Unitsderivative | -2,930 | $0.00 | $0 | 0 | Jan 13, 2026 |
| Jan 1, 2026 | UGI UGI CORP /PA/ | AGrant or award Performance Unitsderivative | +3,055 | $0.00 | $0 | 3,055 | Jan 5, 2026 |
| Jan 1, 2026 | UGI UGI CORP /PA/ | AGrant or award Stock Unitsderivative | +4,569 | $0.00 | $0 | 4,569 | Jan 5, 2026 |
| Nov 20, 2024 | UGI UGI CORP /PA/ | MOption exercise UGI Common Stock | +1,582 | $0.00 | $0 | 4,501 | Nov 22, 2024 |
| Nov 20, 2024 | UGI UGI CORP /PA/ | FTax withholding UGI Common Stock | -434 | $25.02 | $11k | 4,067 | Nov 22, 2024 |
| Nov 20, 2024 | UGI UGI CORP /PA/ | MOption exercise Performance Unitsderivative | -1,950 | $0.00 | $0 | 0 | Nov 22, 2024 |
Questions about Jean Felix Tematio
Answered from the filings on this page, as of the latest one.
Is Jean Felix Tematio buying or selling?
In the last 12 months Jean Felix Tematio reported 0 open-market buys worth $0 and 1 open-market sell worth $489k on SEC Form 4; the latest was sold $489k of UGI on Feb 11, 2026. Grants, option exercises and tax withholding are not counted.
How did Jean Felix Tematio's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jean Felix Tematio has 0.
Where does Jean Felix Tematio file Form 4?
Jean Felix Tematio has filed Form 4 at UGI (UGI CORP /PA/) as VP, CAO & Corporate Controller. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.